Genetic Testing in Pediatric Neuropsychiatric Disorders

Description of the granted funding

Genetic understanding of psychiatric disorders has greatly advanced, leading to calls for this information to be taken to the clinic. We are performing genome analysis in patients with childhood neuropsychiatric disorders, where large impact de novo mutations are more common, in order to see if genetic testing is a useful tool for the clinic. Furthermore, the underlying symptoms in these disorders can vary over time, but it is not possible to predict which children or what symptoms will improve, meaning that treatment and rehabilitation are given on the current presentation of symptoms. Any single genetic variation is neither necessary nor sufficient in the etiology of these disorders and symptoms. Thus, we are also longitudinally collecting a multitude of different levels of biological data that can vary with time, in order to identify potential biomarkers that could be used to better predict disorder progression and outcome, so that treatment and rehabilitation can be personalized.
Show more

Starting year

2020

End year

2025

Granted funding

William Hennah Orcid -palvelun logo
450 000 €

Funder

Research Council of Finland

Funding instrument

Academy projects

Other information

Funding decision number

332583

Fields of science

Genetics, developmental biology, physiology

Research fields

Perinnöllisyystiede

Identified topics

genes, genetics